Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Operating Expenses (2024 - 2025)

Profound Medical has reported Operating Expenses over the past 2 years, most recently at $11.4 million for Q4 2025.

  • Quarterly results put Operating Expenses at $11.4 million for Q4 2025, changed 0.47% from a year ago — trailing twelve months through Dec 2025 was $52.6 million (up 31.29% YoY), and the annual figure for FY2025 was $52.6 million, up 31.29%.
  • Operating Expenses for Q4 2025 was $11.4 million at Profound Medical, down from $12.8 million in the prior quarter.
  • Over the last five years, Operating Expenses for PROF hit a ceiling of $15.4 million in Q2 2025 and a floor of $8.7 million in Q1 2024.